业界动态国内医卫资讯

PD-1阻断联合化疗延长胰腺癌无事件生存期(EFS)

Medscape News · 2026-11-12 02:45

摘要

一项单中心随机试验将检查点抑制剂与四药化疗骨架方案联合,用于毗邻大血管的胰腺肿瘤。获益按可切除性分类出现明显分化。Medscape Medical News

English
PD-1 Blockade Plus Chemo Extends Pancreatic Cancer EFS

A single-center randomized trial paired a checkpoint inhibitor with a four-drug chemotherapy backbone in pancreatic tumors abutting major vessels. The benefit split sharply by resectability class. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界